Rationale and Study Design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims: Increased sympathetic activation and reduced parasympathetic tone are important pathophysiological contributors to the progression of heart failure, and are associated with poor outcome in patients. The aim of this study is to determine if vagal nerve stimulation (VNS) is a promising approach to modulate autonomic function and slow cardiac remodelling and the progression of heart failure. Methods: The NECTAR-HF (NEural Cardiac TherApy foR Heart Failure) trial is designed to evaluate whether the Boston Scientific VNS device is safe and may attenuate cardiac remodelling, improve cardiac function and increase exercise capacity, in symptomatic heart failure patients (New York Heart Association Class II–III) with left ventricular systolic dysfunction (ejection fraction ≤35%) and receiving optimal medical therapy. Patients will be randomized in a 2:1 ratio to receive standard optimal medical treatment plus VNS system in an active mode vs. optimal medical treatment plus VNS system in an inactive mode, for a 6 month period. After the 6 month control period, inactive VNS systems will be activated and all patients will receive VNS. The study is powered to detect differences in the primary efficacy endpoint of change in left ventricular end systolic diameter. Secondary endpoints include ejection fraction, left ventricular volumes, quality of life scores, functional capacity, and changes in biomarkers. Conclusion: This Phase II, randomized clinical trial conducted with vagal stimulation for heart failure will provide important new information on the potential of this novel and promising technique.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bristow, M. R., Saxon, L. A., Boehmer, J., Krueger, S., Kass, D. A., De Marco, T., Carson, P., DiCarlo, L., DeMets, D., White, B. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032423 · Cited by 5,812
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Tracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728
Vanoli, E., De Ferrari, G. M., Stramba-Badiale, M., Hull, S. S., Foreman, R. D., & Schwartz, P. J. (1991) · Circulation Research · doi:10.1161/01.res.68.5.1471 · Cited by 681
Chronic vagus nerve stimulation: A new and promising therapeutic approach for chronic heart failure
De Ferrari, G. M., Crijns, H. J. G. M., Borggrefe, M., Milasinovic, G., Smid, J., Zabel, M., Gavazzi, A., Sanzo, A., Dennert, R., Kuschyk, J., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq391 · Cited by 523
Self-citation
Cited by
Zannad, F., De Ferrari, G. M., Tuinenburg, A. E., Wright, D., Brugada, J., Butter, C., Klein, H., Stolen, C., Meyer, S., Stein, K. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu345 · Cited by 380
Self-citationPremchand, R. K., Sharma, K., Mittal, S., Monteiro, R., Dixit, S., Libbus, I., DiCarlo, L. A., Ardell, J. L., Rector, T. S., Amurthur, B., et al. (2014) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2014.08.009 · Cited by 377
“ART is also being studied in a 96-patient phase II study sponsored by Boston Scientific (St Paul, Minnesota), the Neurocardiac Therapy for Heart Failure (NECTAR-HF) study.(23) In NECTAR-HF, as in ANTHEM-HF, low-amplitude stimulation is not synchronized with the cardiac cycle; however, the Boston Scientific VNS system…”
Clinical neurocardiology defining the value of neuroscience-based cardiovascular therapeutics
Shivkumar, K., Ajijola, O. A., Anand, I., Armour, J. A., Chen, P., Esler, M., De Ferrari, G. M., Fishbein, M. C., Goldberger, J. J., Harper, R. M., et al. (2016) · The Journal of Physiology · doi:10.1113/jp271870 · Cited by 308
Heart–Brain Axis: Effects of Neurologic Injury on Cardiovascular Function
Tahsili-Fahadan, P., & Geocadin, R. G. (2017) · Circulation Research · doi:10.1161/circresaha.116.308446 · Cited by 291
Direct measurement of vagal tone in rats does not show correlation to HRV
Marmerstein, J. T., McCallum, G. A., & Durand, D. M. (2021) · Scientific Reports · doi:10.1038/s41598-020-79808-8 · Cited by 77
Metadata
- Authors
- De Ferrari, G. M., Tuinenburg, A. E., Ruble, S., Brugada, J., Klein, H., Butter, C., Wright, D. J., Schubert, B., Solomon, S., Meyer, S., Stein, K., Ramuzat, A., & Zannad, F.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-20
- Volume
- 16
- Issue
- 6
- Pages
- 692-699
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W1483704015
- Cited by
- 62
- References
- 5
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Rationale and Study Design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF. https://app.cochat.ai/papers/10.1002/ejhf.80
- The paper
- De Ferrari, G. M., Tuinenburg, A. E., Ruble, S., Brugada, J., Klein, H., Butter, C., Wright, D. J., Schubert, B., Solomon, S., Meyer, S., Stein, K., Ramuzat, A., & Zannad, F. (2014). Rationale and Study Design of the NEuroCardiac TherApy foR Heart Failure Study: NECTAR-HF. European Journal of Heart Failure. https://doi.org/10.1002/ejhf.80
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.